The most widely used therapeutic basis for treating AD is the amplification of cholinergic transmission with reversible cholinesterase inhibitors, which are the primary symptomatic treatment for the cognitive deficits that occur in AD [24]. Here, BCHE is linked to Alzheimer disease.